SCHEMBL4551369

SCHEMBL4551369

Cc1ncc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1-c1cc(C(=O)NCC(C)(C)C)n(C)n1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 20/20 0.53
BRAF P15056 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551368 0.89 RAF1 (0.46) RAF1BRAF
SCHEMBL5602980 0.88 RAF1 (0.54) RAF1BRAF
SCHEMBL14473165 0.86 RAF1 (0.48) RAF1BRAF
SCHEMBL5592994 0.85 RAF1 (0.48) RAF1BRAF
SCHEMBL4408603 0.85 RAF1 (0.48) RAF1BRAF
SCHEMBL4728328 0.84 RAF1 (0.54) RAF1BRAF
SCHEMBL4419924 0.84 RAF1 (0.48) RAF1BRAF
SCHEMBL4728307 0.78 RAF1 (0.45) RAF1BRAF
SCHEMBL15074587 0.77 PLAU (0.57) RAF1BRAF
SCHEMBL5623710 0.77 RAF1 (0.50) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed